Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (1203)	6/3/2000 8:31:00 AM
From: scott_jiminez	Read Replies (1) \| Respond to of 4474

The semis and the biotechs had stellar weeks. The former was up ~30%, the latter (my 14 stocks) up 36%. Ariad chose a very good week to make all those positive announcements. The proof is in the data. The (in)famous genomics/bioinformatics list: 5/30 -> 6/02 (avg = +36% +/- 5) 1. aria 82% 2. absc 55 3. glgc 50 4. hysq 44 5. mlnm 41 6. hgsi 40 7. incy 34 8. cra 31 9. genxy 31 10. crgn 28 11. mygn 27 12. gene 20 13. affx 15 14. vgin 8 Since 10/11/99 (avg = 339% +/- 124) 1. aria 1878% 2. hysq 573 3. mygn 374 4. gene 300 5. glgc 278 6. crgn 274 7. absc 249 8. incy 237 9. mlnm 146 10. genxy 142 11. hgsi 135 12. cra 71 13. vgin 60 14. affx 32